Short-term results of early switch from Ranibizumab to Aflibercept in poor or non responder age related macular degeneration in clinical practice

Short-term results of early switch from Ranibizumab to Aflibercept in poor or non responder age related macular degeneration in clinical practice

Abstract Background To evaluate the change in best corrected visual acuity (VA) and central macular thickness (CMT) following treatment with intravitreal aflibercept (AFL) in patients poorly responders or non responders to ranibizumab (RBZ). Methods Charts of patients injected with RBZ from January...

Full description

Bibliographic Details
Main Authors: Luciana de Sá Quirino-Makarczyk, Maria de Fátima Sainz Ugarte, Bruna Viana Vieira, Sérgio Kniggendorf, Caio Vinicius Saito Regatieri
Format: Article
Language:English
Published: BMC 2020-05-01
Series:International Journal of Retina and Vitreous
Subjects:
Aflibercept
Ranibizumab
Age-related macular degeneration
Vascular endothelial growth factor
Online Access:http://link.springer.com/article/10.1186/s40942-020-00212-5

Internet

http://link.springer.com/article/10.1186/s40942-020-00212-5

Similar Items